TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ALXO

Alx Oncology Holdings 

Healthcare · Biotechnology

1.40$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

Alx Oncology Holdings  (ALXO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ALXO
Line item 2018 2019 2020 2021 2022 2023 2024 2025
2.1 4.8 1.2 0.0 0.0 0.0 0.0 0.0
1.9 4.4 1.1 0.7 1.5 0.8 0.9 –
0.2 0.4 0.1 -0.7 -1.5 -0.8 -0.9 –
11 16 29 60 98 142 116 77
2.6 3.3 15 23 29 28 26 24
14 20 44 84 127 170 142 104
-14 -19 -44 -84 -127 -170 -142 -104
0.0 0.0 0.8 0.0 4.4 1.6 1.7 1.6
-14 -19 -45 -83 -123 -161 -135 -102
0.0 0.0 0.2 0.0 0.1 – – –
-14 -19 -46 -83 -123 -161 -135 -102
-13 -19 -43 -83 -127 -158 -132 -99

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?